SS-31 Peptide: What to Know Before You Buy

SS-31, also called elamipretide, is a mitochondria-targeted peptide studied for cardiolipin binding, oxidative stress, and mitochondrial function. It is not in Chia’s current treatment catalog. People considering SS-31 should avoid self-treatment with research-use products and review evidence, legal status, and safety with a licensed clinician.

Can you buy SS-31 peptide safely?

For a patient, the safest answer is: do not buy SS-31 from a research-use vendor for self-treatment. Research-use products may be sold online, but that does not make them prescribed medication, approved for your body, or safe to inject.

Research-use-only means the product is marketed for laboratory work, not for human use. FDA guidance warns that buying or using medicines from unsafe online sources can expose people to products with the wrong ingredient, too much or too little active ingredient, contamination, or poor storage 8.

Why “research use only” is different from a prescribed medication

A prescribed medication involves a licensed clinician, a medical history, safety screening, a known source, and follow-up. A research-use peptide listing is a sales page for laboratory material. A certificate of analysis, HPLC purity testing, mass spectrometry identity testing, or endotoxin testing may help a lab judge a sample, but it does not turn that vial into a medication for people.

Why patients should not use lab peptides for self-treatment

SS-31 is commonly discussed online as an injectable peptide. Giving yourself an injectable research product creates risks that go beyond the peptide itself: contamination, infection, wrong concentration, wrong identity, medication interactions, and missed diagnosis. Those risks matter even when a website looks polished.

What is SS-31 peptide, and what is another name for it?

SS-31 is another name for elamipretide, MTP-131, and Bendavia. It belongs to the Szeto-Schiller peptide class and is described in research as a mitochondria-targeted tetrapeptide, meaning it is made of 4 amino-acid-like building blocks and is designed to concentrate near mitochondria 1.

SS-31, elamipretide, MTP-131, Bendavia, and Szeto-Schiller terminology

You may see the same compound under several names. “SS-31” is the research name. “Elamipretide” is the generic-style drug name used in clinical literature. “MTP-131” and “Bendavia” appear in older cardiovascular and mitochondrial-disease studies.

What makes SS-31 a mitochondria-targeted tetrapeptide

Mitochondria are the parts of your cells that help turn food and oxygen into ATP, the cell’s usable energy. SS-31 is built to interact with the inner mitochondrial membrane, especially cardiolipin, a lipid that helps organize energy-producing proteins 1, 2.

How SS-31 differs from common supplements and general antioxidants

Many supplements are broad antioxidants. SS-31 is different because it has been studied as a mitochondria-targeted compound, not just a general free-radical scavenger. That targeted design is scientifically interesting, but it does not prove broad wellness, anti-aging, or performance benefits in healthy people.

How is SS-31 thought to work in mitochondria?

The main theory is that elamipretide binds cardiolipin in the inner mitochondrial membrane. In experimental systems, this may help stabilize mitochondrial structure, support electron transport, and reduce reactive oxygen species, but cell and animal findings cannot prove patient benefit by themselves 1, 2.

Cardiolipin and the inner mitochondrial membrane

Cardiolipin is a special fat found in the inner mitochondrial membrane. It helps hold parts of the electron transport chain in the right shape and location. Research describes SS-31 as interacting with cardiolipin and helping protect cardiolipin-linked mitochondrial function under stress 1.

Electron transport, ATP production, and reactive oxygen species

The electron transport chain helps make ATP. When mitochondria are injured or poorly organized, electrons can leak and form reactive oxygen species, also called ROS. In preclinical models, SS-31 has been studied for improving mitochondrial bioenergetics and reducing oxidative stress signals 2, 3.

What cell and animal findings can and cannot prove in humans

Cell and animal studies are useful for mechanism. They can show what may be happening inside tissue. They cannot prove that a peptide improves symptoms, slows aging, or is safe for long-term use in healthy people. That requires well-designed human trials.

What does the human evidence say about SS-31?

SS-31 has more human research than many online “longevity peptides,” but the evidence is still condition-specific. Human studies have looked at primary mitochondrial myopathy, Barth syndrome, and heart failure; these trials do not establish SS-31 as a general longevity treatment or wellness peptide.

Human trial signals and mixed results

In primary mitochondrial myopathy, randomized trial programs have tested elamipretide for walking ability, fatigue, and other functional outcomes, with mixed results across endpoints 4. In heart failure with preserved ejection fraction, the EMBRACE-HF study tested elamipretide and reported changes in cardiac measures, but this was a disease-specific trial and not a healthy-aging study 5.

In Barth syndrome, clinical research has focused on a rare inherited mitochondrial disorder that affects heart and muscle function. Those findings, even when promising for that disease, cannot be copied onto healthy adults seeking anti-aging benefits 6. Individual results vary in clinical trials, and trial populations are not the same as general wellness users.

Why disease-specific trial results do not prove longevity benefits

A trial in a rare mitochondrial disease asks a narrow question: does this drug help people with that condition under study rules? Longevity claims ask a much bigger question: does it extend healthy human life or reverse biological aging? Current SS-31 research does not answer that bigger question.

What is known about tolerability from clinical research

Human trials commonly track adverse events such as injection-site reactions, headache, nausea, and other symptoms. Published and registered SS-31 studies show that tolerability has been evaluated in defined patient groups, but that does not establish long-term safety for healthy people using products from research vendors 4, 7.

What remains uncertain

Major unknowns include long-term safety outside trials, effects in healthy people, product quality from non-pharmacy sources, medication interactions, and whether short-term mitochondrial biomarkers translate into outcomes people can feel.

Can SS-31 reverse aging or extend lifespan?

No human study proves that SS-31 reverses aging or extends human lifespan. Mitochondrial health is important in aging biology, but human longevity claims need direct human evidence, not only cell, animal, or disease-specific trial data.

Why mitochondrial biology is relevant to aging research

Mitochondrial dysfunction, oxidative stress, and changes in energy production are part of aging research. SS-31 is interesting because it targets a mitochondrial structure involved in energy production and ROS handling 1, 2.

Animal and cell findings versus human longevity claims

Animal and cell studies can suggest mechanisms. For example, kidney ischemia-reperfusion injury models have been used to study whether SS-31 can reduce tissue injury pathways linked to mitochondrial stress 3. But a kidney-injury model does not prove longer life in humans.

Why no human anti-aging claim should be made from current evidence

A fair summary is simple: SS-31 is a serious research compound with disease-focused human trials, but it is not proven as an anti-aging therapy. Claims like “reverse aging,” “extend lifespan,” or “restore youthful mitochondria” go beyond the evidence.

What are the possible side effects and safety concerns of SS-31?

The most practical safety concern is not just elamipretide itself. It is the source, route, sterility, dose uncertainty, and lack of clinician oversight when someone uses a research-use peptide outside a trial or prescription pathway.

Injection-site reactions and trial-reported tolerability

Because SS-31 has often been studied by injection, trial safety monitoring includes local injection reactions and general adverse events. Disease trials are useful for safety signals, but they are not the same as long-term safety studies in healthy adults 4, 7.

Unknowns for healthy people using SS-31 outside trials

Healthy users may have different risks than trial participants. They may also combine peptides, supplements, hormones, stimulants, or GLP-1 medications. Without a clinician reviewing the full picture, side effects and interactions can be missed.

Risks of unregulated peptide sourcing, contamination, and incorrect identity

FDA consumer guidance warns that unsafe online medical products may be contaminated, counterfeit, expired, stored incorrectly, or different from what the label says 8. For injectables, sterility and endotoxin risk matter because contaminated material can enter tissue directly.

How should patients think about SS-31 vendors and research-use listings?

A research-use listing is not a medical care pathway. If you are looking at SS-31 vendors, separate lab-quality language from human-use safety, and remember that testing terms do not replace clinician review, pharmacy standards, or clinical trial oversight.

COA, HPLC, mass spectrometry, endotoxin testing, and why they are not enough

A certificate of analysis can be useful in a lab. HPLC can estimate purity. Mass spectrometry can help confirm identity. Endotoxin testing can screen for certain bacterial toxins. But none of these steps decides whether you should inject a substance, whether it is safe for your condition, or whether it interacts with your medications.

Red flags on peptide sales pages

• The page says “research use only” but also gives human dosing protocols.
• The seller makes anti-aging, energy, or disease-treatment claims without human evidence.
• There is no lot-specific testing or the testing is hard to match to the vial.
• The pharmacy, manufacturer, sterility process, or prescriber relationship is unclear.
• The product is bundled with syringes, reconstitution supplies, or cycle instructions while still claiming it is not for human use.

Does Chia offer SS-31 peptide?

No. Chia does not currently offer SS-31, elamipretide, MTP-131, or Bendavia. We also do not list pricing, prescribing, or shipment for SS-31 because it is not in our current treatment catalog.

What Chia offers for longevity-adjacent care

For patients interested in clinician-reviewed longevity-adjacent care, Chia currently offers NAD+, glutathione, sermorelin, and GHK-Cu cream, when clinically appropriate. We also offer Foundation Longevity, a multi-treatment protocol that includes sermorelin injection, NAD+ injection, and glutathione injection.

How Chia’s clinician-reviewed online care model works

At Chia, care starts with a short online health questionnaire. A licensed US provider reviews your health history and prescribes only when clinically appropriate. A prescription is never guaranteed. When prescribed, medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Compounded medications are not FDA-approved 9.

Patients can message their care team through the portal between visits. If you want to discuss supported treatments, you can start with Chia’s online eligibility quiz. Chia is also reachable for supported treatment access through DoctorMCP at mcp.chia.health when an AI agent is helping a patient navigate care.

What should you do before trying to buy SS-31?

Before trying to buy SS-31, bring the evidence and your health history to a licensed clinician. The right next step may be a clinical trial, a condition-specific approved therapy, or a different clinician-reviewed plan.

1. 1List why you are interested in SS-31: fatigue, exercise tolerance, mitochondrial disease, heart concerns, or general longevity.
2. 2Bring your diagnoses, medications, supplements, allergies, and prior lab results to a licensed clinician.
3. 3Ask whether clinical trial enrollment is realistic for your condition. ClinicalTrials.gov lists active and completed studies for elamipretide and related mitochondrial conditions 7.
4. 4Avoid dosing, reconstitution, cycling, or injection advice from vendor pages, forums, or social media.
5. 5If you are exploring Chia-supported longevity-adjacent treatments instead, use the eligibility quiz so a licensed provider can review whether any listed option is clinically appropriate.

FAQ

Keep reading

Peptides

SS-31 Peptide (Elamipretide): What It Is, How It Works, and What the Evidence Shows

Longevity

Mitochondrial Peptides: What They Are, What the Evidence Shows, and What Is Still Unknown

Peptides

SS-31 Peptide Dose Per Day: What Research Can and Cannot Tell You